Controlled release formulations having rapid onset and rapid...

Details Controlled release formulations having rapid onset and rapid... Controlled release formulations having rapid onset and rapid...

2007-07-24

2007-07-24

Tran, Susan (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C424S451000, C424S452000, C424S489000, C424S491000, C424S497000

Reexamination Certificate

active

10156622

ABSTRACT:
The invention is directed to oral modified/controlled release drug formulations which provide a rapid initial onset of effect and a prolonged duration of effect. Preferably, the peak concentration is lower than that provided by the reference standard for immediate release formulations of the drug, and the duration of effect falls rapidly at the end of the dosing interval.

REFERENCES:
patent: 4256108 (1981-03-01), Theeuwes
patent: 5133974 (1992-07-01), Paradissis et al.
patent: 5202128 (1993-04-01), Morella et al.
patent: 5286493 (1994-02-01), Oshlack et al.
patent: 5326570 (1994-07-01), Rudnic et al.
patent: 5580578 (1996-12-01), Oshlack et al.
patent: 5639476 (1997-06-01), Oshlack et al.
patent: 5837284 (1998-11-01), Mehta et al.
patent: 5874090 (1999-02-01), Baker et al.
patent: 5885616 (1999-03-01), Hsiao et al.
patent: 6077533 (2000-06-01), Oshlack et al.
patent: 6093420 (2000-07-01), Baichwal
patent: 6214379 (2001-04-01), Hermelin
patent: 6255325 (2001-07-01), Dariani et al.
patent: 6419960 (2002-07-01), Krishnamurthy et al.
patent: 6730325 (2004-05-01), Devane et al.
patent: 2001/0012847 (2001-08-01), Lam et al.
patent: 1297368 (1992-03-01), None
patent: 0239361 (1987-09-01), None
patent: 0519870 (1992-12-01), None
patent: WO 92 21333 (1992-12-01), None
patent: WO 97 03672 (1997-02-01), None
patent: WO 97/03672 (1997-02-01), None
patent: WO 97 03673 (1997-02-01), None
patent: WO 98 14168 (1998-04-01), None
patent: 98/23263 (1998-06-01), None
patent: 9823263 (1998-06-01), None
patent: 9962496 (1999-12-01), None
patent: 0025752 (2000-05-01), None
Database HCAPLUS on STN, American Chemical Society, AN 1997-686114, Erramousepe et al., “Effect on Dissolution from Halving Methylphenidate Extended-Release Tablets,” abstract, Ann. Pharmacother., 1997, 31(10), 1123-1126.

Affiliated with

Also associated with

Rating

Controlled release formulations having rapid onset and rapid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release formulations having rapid onset and rapid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulations having rapid onset and rapid... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3729848